CYGNAL THERAPEUTICS
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87469833
- Registration number
- 6335320
- Mark type
- Stylized text
- Filed
- 31 May 2017
- Published for opposition
- 23 Jan 2018
- Registered
- 27 Apr 2021
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and immune system related diseases
Owner
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- VL41, Inc., Cambridge, MA, US
- VL41, Inc., Cambridge, MA, US
Prosecution history
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2021 — USE AMENDMENT FILED
- 17 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 26 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2020 — SOU EXTENSION 5 GRANTED
- 21 Sept 2020 — SOU EXTENSION 5 FILED
- 21 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2020 — SOU EXTENSION 4 GRANTED
- 18 Mar 2020 — SOU EXTENSION 4 FILED
- 18 Mar 2020 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED